# US 2026/0092071 A1 · Compounds and compositions as smarca2/4 degraders and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092071 A1
- Document ID: US20260092071A1
- Status: Published application
- Kind: A1
- Application number: 19/112,750
- Filed: 2023-09-22
- Published: 2026-04-02
- Earliest claimed: 2022-09-23
- Assignees: The Regents of the University of Michigan; Oncopia Therapeutics, Inc. d/b/a SK Life Science Labs
- Applicants: Regents of the University of Michigan; Oncopia Therapeutics, Inc. d/b/a SK Life Science Labs
- Inventors: Shaomeng Wang; Lingying Leng; Lin Yang; Wenbin Tu; Liyue Huang; Mi Wang; Wei Jiang; Paul Kirchhoff; Guozhang Xu; Zhenwu Li; Lalgudi Harikrishnan; E. Scott Priestley; Jelena Tosovic; Jeanne Stuckey
- Web page: https://patentgrep.com/patent/US20260092071A1

## CPC

- C07D 487/10: Spiro-condensed systems
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/527: spiro-condensed
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/541: Non-condensed thiazines containing further heterocyclic rings
- A61P 35/00: Antineoplastic agents
- C07D 471/14: Ortho-condensed systems
- C07D 471/20: Spiro-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 487/20: Spiro-condensed systems
- C07D 491/20: Spiro-condensed systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Described herein are compounds of Formula II and their pharmaceutically acceptable salts, solvates, or stereoisomers, as well as their uses (e.g., as SMARCA2 or SMARCA4 degraders).

## Claims

### Claim 1

A compound of Formula II
or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein:
T is of Formula II-1
wherein:
A1 is CRA1 or N;
A2 is CRA2 or N;
A3 is CRA3 or N;
A4 is CRA4 or N;
RA1, RA2, RA3, and RA4 are independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRcS(═O)2Ra, —NRcS(═O)Ra, —NRcS(═O)2ORb, —NRc S(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORb, —OS(═O)2Ra, —OS(═O)2ORb, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
each RC is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRc S(═O)2Ra, —NRc S(═O)Ra, —NRc S(═O)2ORa, —NRcS(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORb, —OS(═O)2Ra, —OS(═O)2ORb, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
two RC together form an oxo; or
two RC, together with the carbon atom to which they are attached, form Ring D
Ring D is C3-12 carbocycle or 3- to 12-membered heterocycle;
each RD is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRc S(═O)2Ra, —NRc S(═O)Ra, —NRc S(═O)2ORb, —NRcS(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORb, —OS(═O)2Ra, —OS(═O)2ORb, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)OR, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
d is an integer selected from 0 to 10, as valency permits;
E1 is CRE1 or N;
E2 is CRE2 or N;
E3 is CRE3 or N;
E4 is CRE4 or N;
RE1, RE2, RE3, and RE4 are independently
hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRc S(═O)2Ra, —NRc S(═O)Ra, —NRc S(═O)2OR′, —NRcS(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORb, —OS(═O)2Ra, —OS(═O)2ORb, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
wherein one of RE1, RE2, RE3, and RE4 is
or
one of RE2, RE3, or RE4 is
denotes attachment to L;
Ring F is C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl;
each RF is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRc S(═O)2Ra, —NRc S(═O)Ra, —NRcS(═O)2ORb, —NRcS(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORb, —OS(═O)2Ra, —OS(═O)2ORb, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru; and
f is an integer selected from 0 to 10, as valency permits,
L is of Formula II-2
wherein:
* denotes attachment to T and ** denotes attachment to V;
each L′ is independently C1-6 alkylene, C1-6 heteroalkylene, C2-6 alkenylene, C2-6 alkynylene, C3-12 carbocyclylene, 3- to 12-membered heterocyclylene, C6-10 arylene, 5- to 10-membered heteroarylene, —C(═O)—, —C(═O)N(RL′)—, —C(═O)O—, —N(RL′)—, —O—, —S—, or —S(═O)2—, wherein the alkylene, heteroalkylene, alkenylene, alkynylene, carbocyclylene, heterocyclylene, arylene, or heteroarylene is optionally substituted with one or more Ru;
each occurrence of RL′ is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —S(═O)2R®, —S(═O)2ORb, —S(═O)2NRcRd, —C(═O) R*, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru; and
l is an integer selected from 0 to 5,
V is of Formula II-3-i, II-3-ii, II-3-iii, II-3-iv, II-3-v, II-3-vi, II-3-vii, or II-3-viii
wherein:
** denotes attachment to L;
Ring A′ is 5- to 7-membered heterocycle;
each RA′ is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
a′ is an integer selected from 0 to 10, as valency permits;
Ring B′ is C3-6 carbocycle or 3- to 6-membered heterocycle;
each RB′ is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
b′ is an integer selected from 0 to 10, as valency permits;
Ring C′ is C6 aryl or 5- to 6-membered heteroaryl;
each RC′ is independently halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
c′ is an integer selected from 0 to 5, as valency permits;
Ring D′ is C6 aryl or 5- to 6-membered heteroaryl;
each RD′ is independently halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru; or
RD′ and RV4, together with the intervening atoms, form C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
d′ is an integer selected from 0 to 5, as valency permits; Ring E′ is C3-8 carbocycle or 3- to 8-membered heterocycle;
each RE′ is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
e′ is an integer selected from 0 to 5, as valency permits;
Ring F′ is C6 aryl or 5- to 6-membered heteroaryl;
each RF′ is independently halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
f′ is an integer selected from 0 to 5, as valency permits;
RV1 is —N(RV1i)C(═O)RV1ii or 5- to 6-membered heteroaryl optionally substituted with one or more Ru;
RV1i is hydrogen, C1-6 alkyl, C3-6 carbocyclyl, or 3- to 6-membered heterocyclyl, wherein the alkyl, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru;
RV1i is C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more RV1iia,
each RV1ia is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, —(C1-6 alkylene)-(3- to 12-membered heterocyclyl), C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkylene, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
RV2 is hydrogen, C1-6 alkyl, C3-12 carbocyclyl, or 3- to 12-membered heterocyclyl, wherein the alkyl, carbocyclyl, heterocyclyl is optionally substituted with one or more Ru;
RV3 is hydrogen, C1-6 alkyl, C3-6 carbocyclyl, 3- to 6-membered heterocyclyl, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru;
each RV4 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, or 3- to 6-membered heterocyclyl, wherein the alkyl, alkenyl, alkynyl, carbocyclyl, or heterocyclyl is optionally substituted with one or more RV4a, or
two RV4, together with the carbon atom to which they are attached, form C3-6 carbocycle or 3- to 6-membered heterocycle, wherein the carbocycle or heterocycle is optionally substituted with one or more Ru;
each RV4a is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-12 heteroalkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —C(═O)ORb, or —C(═O)NRcRd, wherein the alkyl, heteroalkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru; and
RV5 is hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, or —C(═O)Ra, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru;
wherein:
each Ru is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, 5- to 10-membered heteroaryl, —SRb, —S(═O)Ra, —S(═O)2Ra, —S(═O)2ORb, —S(═O)2NRcRd, —NRc S(═O)2Ra, —NRc S(═O)Ra, —NRc S(═O)2ORa, —NRc S(═O)2NRcRd, —NRbC(═O)NRcRd, —NRbC(═O)Ra, —NRbC(═O)ORa, —OS(═O)2Ra, —OS(═O)2OR, —OS(═O)2NRcRd, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —C(═O)Ra, —C(═O)ORb, or —C(═O)NRcRd; wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more substituents selected from oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, and 3- to 6-membered heterocyclyl; or
two Ru, together with the one or more intervening atoms, form C3-6 carbocyclyl, 3- to 6-membered heterocyclyl, C6 aryl, or 5- to 6-membered heteroaryl, wherein the carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Rz;
each Ra is independently C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl;
each Rb is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl; and
each Rc and Rd is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl; or
Rc and Rd, together with the nitrogen atom to which they are attached, form 3- to 12-membered heterocyclyl,
wherein each occurrence of Ra, Rb, Rc, and Rd is independently and optionally substituted with one or more Rz; and
each Rz is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, or 3- to 6-membered heterocyclyl.

### Claim 2 (depends on 1)

The compound of claim 1, wherein T is of Formula II-1-i or II-1-ii
wherein:
each RC is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 3 (depends on 1)

The compound of claim 1, wherein T is of Formula II-1-i-1, II-1-i-2, II-1-i-3, II-1-ii-1, II-1-ii-2, II-1-ii-3, II-1-iii-1, II-1-iii-2, or II-1-iii-3
wherein:
each RC is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 4 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein RA1 is hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 5 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein RAI is halogen or hydrogen.

### Claim 6 (depends on 1)

The compound of claim 1, wherein T is of Formula II-1-i-4, II-1-i-5, II-1-i-6, II-1-ii-4, II-1-ii-5, II-1-ii-6, II-1-iii-4, II-1-iii-5, or II-1-iii-6
wherein
each RC is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru; and
RA1 is halogen or hydrogen.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The compound of any one of claims 1-6, wherein Ring F is 3- to 12-membered heterocyclyl or C3-12 carbocyclyl.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

The compound of any one of claims 1-6, wherein Ring F is 5- to 6-membered heteroaryl.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The compound of any one of claims 1-8, wherein each RF is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The compound of any one of claims 1-9, wherein f is 0.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein RE1, RE2, and RE4, RE1, RE3, and RE4, or RE1, RE2, and RE3 are independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 12 (depends on 11)

The compound of claim 11, wherein each of RE1, RE2, and RE4, each of REI, RE3, and RE4, or each of RE1, RE2, and RE3 is hydrogen.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein one or two of E1, E2, and E4, one or two of E1, E3, and E4, or one or two of E1, E2, and E3 are N.

### Claim 14 (depends on 13)

The compound of claim 13, wherein one or two of RE1, RE2, and RE4, one or two of REI, RE3, and RE4, or one or two of RE1, RE2, and RE3 are independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 15 (depends on 14)

The compound of claim 14, wherein one or two of RE1, RE2, and RE4, one or two of RE1, RE3, and RE4, or one or two of RE1, RE2, and RE3 are hydrogen.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The compound of any one of claims 1-15, wherein each of RA2, RA3, and RA4 is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The compound of any one of claims 1-15, wherein each of RA2, RA3, and RA4 is hydrogen.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound of any one of claims 1-17, wherein Ring D is C3-12 carbocycle.

### Claim 19 (depends on 18)

The compound of claim 18, wherein Ring D is C5-7 carbocycle.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound of any one of claims 1-17, wherein Ring D is 3- to 12-membered heterocycle.

### Claim 21 (depends on 20)

The compound of claim 20, wherein Ring D is 5- to 7-membered heterocycle.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The compound of any one of claims 1-21, wherein each RD is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, 3- to 12-membered heterocyclyl, C6-10 aryl, or 5- to 10-membered heteroaryl, wherein the alkyl, alkoxy, alkylamino, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one or more Ru.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The compound of any one of claims 1-22, wherein d is 0.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound of any one of claims 1-17, wherein each RC is independently hydrogen, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-6 carbocyclyl, or 3- to 6-membered heterocyclyl, wherein the alkyl, alkoxy, alkylamino, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The compound of any one of claims 1-17, wherein each RC is independently C1-6 alkyl optionally substituted with one or more halogen.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-i

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-ii

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-iii

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-v

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-vi

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The compound of any one of claims 1-25, wherein V is of Formula II-3-vii

### Claim 32 (depends on 26, 27, 28, 29, 30, 31)

The compound of any one of claims 26-31, wherein RV1 is —N(RV1i)C(═O)RV1ii or 5-membered heteroaryl, wherein RV1ii is C3-6 carbocyclyl optionally substituted with one or more RV1ia, and the heteroaryl is optionally substituted with one or more Ru.

### Claim 33 (depends on 32)

The compound of claim 32, wherein each RV1iia is independently halogen, —CN, C1-6 alkyl, (C1-6 alkylene)-(3- to 12-membered heterocyclyl), or C1-6 alkylamino, wherein the alkyl, alkylene, or alkylamino is optionally substituted with one or more Ru.

### Claim 34 (depends on 26, 27, 28, 29, 30, 31, 32, 33)

The compound of any one of claims 26-33, wherein RV2 is hydrogen, C1-6 alkyl, C5-6 carbocyclyl, or 5- to 6-membered heterocyclyl.

### Claim 35 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34)

The compound of any one of claims 26-34, wherein each RV4 is independently hydrogen or C1-6 alkyl optionally substituted with one or more RV4a.

### Claim 36 (depends on 35)

The compound of claim 35, wherein each RV4a is independently —OH, C1-6 heteroalkyl, C1-6 alkylamino, or 3- to 12-membered heterocyclyl, wherein the heteroalkyl, alkylamino, or heterocyclyl is optionally substituted with one or more Ru.

### Claim 37 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34)

The compound of any one of claims 26-34, wherein RD′ and RV4, together with the atoms to which they are bonded, form C3-12 carbocyclyl or 5- to 10-membered heteroaryl, wherein the carbocyclyl or heteroaryl is optionally substituted with one or more Ru.

### Claim 38 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The compound of any one of claims 26-37, wherein Ring C′ is 5-membered heteroaryl.

### Claim 39 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The compound of any one of claims 26-38, wherein each RC′ is independently halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-6 carbocyclyl, 3- to 6-membered heterocyclyl, wherein the alkyl, alkoxy, alkylamino, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru.

### Claim 40 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The compound of any one of claims 26-39, wherein c′ is 0 or 1.

### Claim 41 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The compound of any one of claims 26-40, wherein Ring E′ is 5- to 6-membered heterocycle.

### Claim 42 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The compound of any one of claims 26-41, wherein each RE′ is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-6 carbocyclyl, 3- to 6-membered heterocyclyl, wherein the alkyl, alkoxy, alkylamino, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru.

### Claim 43 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The compound of any one of claims 26-42, wherein e′ is 0.

### Claim 44 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The compound of any one of claims 26-43, wherein Ring F′ is 5- to 6-membered heteroaryl.

### Claim 45 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The compound of any one of claims 26-44, wherein each RF′ is independently oxo, halogen, —CN, —NO2, —OH, —NH2, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C3-6 carbocyclyl, 3- to 6-membered heterocyclyl, wherein the alkyl, alkoxy, alkylamino, carbocyclyl, or heterocyclyl is optionally substituted with one or more Ru.

### Claim 46 (depends on 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The compound of any one of claims 26-45, wherein f′ is 0.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The compound of any one of claims 1-46, wherein
is

### Claim 48 (depends on 47)

The compound of claim 47, wherein a′ is 1 or 2, and at least one of RA′ is —OH.

### Claim 49 (depends on 48)

The compound of claim 48, wherein
is

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The compound of any one of claims 1-49, wherein Ring D′ is phenyl.

### Claim 51 (depends on 50)

The compound of claim 50, wherein
is

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The compound of any one of claims 1-51, wherein d′ is 0.

### Claim 53 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The compound of any one of claims 1-52, wherein RV3 is hydrogen.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The compound of any one of claims 1-53, wherein RV5 is halogen, C2-6 alkynyl, C6-10 aryl, 5- to 6-membered heteroaryl, or —C(═O)Ra, wherein the alkynyl, aryl, or heteroaryl is optionally substituted with one or more R.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The compound of any one of claims 1-54, wherein each L′ is independently C1-6 alkylene, C1-6 heteroalkylene, C2-6 alkynylene, C3-12 carbocyclylene, 3- to 12-membered heterocyclylene, C6-10 arylene, 5- to 10-membered heteroarylene, —C(═O)—, —C(═O)N(RL′)—, —C(═O)O—, —N(RL′)—, —O—, or —S(═O)2—, wherein the alkylene, heteroalkylene, carbocyclylene, heterocyclylene, arylene, or heteroarylene is optionally substituted with one or more Ru, and l is an integer selected from 1 to 4.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The compound of any one of claims 1-53, wherein each L′ is independently C1-6 alkylene, C1-6 heteroalkylene, C2-6 alkynylene, C3-12 carbocyclylene, 3- to 12-membered heterocyclylene, —C(═O)—, —C(═O)N(RL′)—, —C(═O)O—, —N(RL′)—, —O—, or —S(═O)2—, wherein the alkylene, heteroalkylene, carbocyclylene, or heterocyclylene is optionally substituted with one or more Ru, and l is an integer selected from 1 to 4.

### Claim 57 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The compound of any one of claims 1-54, wherein L is absent, C1-12 alkylene, C1-6 heteroalkylene, C3-12 carbocyclylene, *—C1-12 alkylene-O—, *—C1-12 alkynylene-O—, *—(C1-12 alkylene)-(C1-12 alkynylene)-, *—(C1-12 alkylene)-O—(C1-12 alkynylene)-, *—(C3-12 carbocyclylene)-O—, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-, *—(C3-12 carbocyclylene)-(C1-6 alkylene)-, *—(C3-12 carbocyclylene)-(C1-6 alkylene)-O—, *—(C3-12 carbocyclylene)-(C1-6 heteroalkylene)-, *—C(═O)—(C1-6 alkylene)-, *—C(═O)—(C3-12 carbocyclylene)-, *—C(═O)-(3- to 12-membered heterocyclylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-O—, *-(3- to 12-membered heterocyclylene)-(C1-6 alkylene)-(C3-12 carbocyclylene)-, *—(C1-6 alkylene)-(3- to 12-membered heterocyclylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-C(═O)N(RL′)—, *-(3- to 12-membered heterocyclylene)-(C1-6 alkylene)-, *—(C1-6 alkylene)-C(═O)-(3- to 12-membered heterocyclylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-C(═O)-(3- to 12-membered heterocyclylene)-, *—(C3-12 carbocyclylene)-N(RL′)—C(═O)—(C1-6 alkylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-N(RL′) C(═O)—(C1-6 alkylene)-, *-(3- to 12-membered heterocyclylene)-C(═O)—, *—(C1-6 alkylene)-(3- to 12-membered heterocyclylene)-C(═O)—, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-C(═O)N(RL′)—(C1-6 alkylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-C(═O)—(C1-6 alkylene)-, *-(3- to 12-membered heterocyclylene)-C(═O)—(C1-6 alkylene)-, *—(C3-12 carbocyclylene)-N(RL′) C(═O)—(C1-6 alkylene)-O—, *—(C1-6 alkylene)-N(RL′) C(═O)—(C1-6 alkylene)-, *—(C1-6 alkylene)-O—(C1-6 alkylene)-N(RL′) C(═O)—, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-(C1-6 alkylene)-, *—(C1-6 alkylene)-(C3-12 carbocyclylene)-O—, *—(C1-6 alkylene)-(C6-10 arylene)-, *—S(═O)2—(C3-12 carbocyclylene)-, or *—(C1-6 alkylene)-(5- to 10-membered heteroarylene)-, wherein the alkylene, heteroalkylene, heterocyclylene, carbocyclylene, arylene, or heteroarylene is optionally substituted with one or more Ru, and *denotes attachment to T.

### Claim 58

A compound selected from the compounds in Tables 1 and 2, or a pharmaceutically acceptable salt thereof.

### Claim 59 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

A pharmaceutical composition comprising the compound of any one of claims 1-58, and a pharmaceutically acceptable excipient.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

A method of degrading a SMARCA2 or SMARCA4 protein in a patient or biological sample comprising contacting said patient or biological sample with a compound of any one of claims 1-58.

### Claim 61 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

Use of a compound of any one of claims 1-58 in the manufacture of a medicament for degrading a SMARCA2 or SMARCA4 protein in a patient or biological sample.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

A compound of any one of claims 1-58 for use in degrading a SMARCA2 or SMARCA4 protein in a patient or biological sample.

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

A method of treating a disease or disorder comprising administering to a patient in need thereof a compound of any one of claims 1-58.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

Use of a compound of any one of claims 1-58 in the manufacture of a medicament for treating a disease or disorder.

### Claim 65 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

A compound of any one of claims 1-58 for use in treating a disease or disorder.

### Claim 66 (depends on 63, 64, 65)

The method, use, or compound for use of any one of claims 63-65, wherein the disease or disorder is a SMARCA2 or SMARCA4 protein-mediated disease or disorder.

### Claim 67 (depends on 63, 64, 65)

The method, use, or compound for use of any one of claims 63-65, wherein the disease or disorder is cancer.

### Claim 68 (depends on 67)

The method, use, or compound for use of claim 67, wherein the cancer is selected from NSCLC adenocarcinoma (LUAD), NSCL squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), uterine corpus endometrial carcinoma (UCEC), esophageal carcinoma (ESCA), skin cutaneous melanoma (SKCM), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), bladder urothelial carcinoma (BLCA), and uterine carcinosarcoma (UCS).

### Claim 69 (depends on 67)

The method, use, or compound for use of claim 67, wherein the cancer is selected from NSCLC adenocarcinoma (LUAD), NSCL squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), and uterine corpus endometrial carcinoma (UCEC).
